A relaxin-based nanotherapy for liver fibrosis
Nat Nanotechnol
.
2021 Apr;16(4):365-366.
doi: 10.1038/s41565-020-00832-w.
Authors
Jonathan A Fallowfield
1
,
Prakash Ramachandran
2
Affiliations
1
Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK. jonathan.fallowfield@ed.ac.uk.
2
Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
PMID:
33495619
DOI:
10.1038/s41565-020-00832-w
No abstract available
Publication types
Comment
MeSH terms
Humans
Liver Cirrhosis / drug therapy
Relaxin* / therapeutic use
Substances
Relaxin
Grants and funding
G84/6205/MRC_/Medical Research Council/United Kingdom
MR/N008340/1/MRC_/Medical Research Council/United Kingdom